Cross-industry synergies. More opportunities for animal health.
Akretiv's Special Purpose Vehicle (SPV) pipeline includes selected animal-health programs we originate or co-develop in collaboration with human biotechnology companies. We focus on technologies where an established scientific foundation may be applied to meaningful unmet needs in veterinary medicine.
Each program is organized around specific evidence needs, development milestones and capital requirements. Akretiv provides development leadership and coordinates the regulatory, scientific, commercial and specialist resources needed to advance the opportunity.
Dedicated SPVs are the planned structure for project-specific financing, governance and economics when appropriate. This allows capital to be directed toward clearly defined development objectives while keeping each program's risks, rights and economics transparent.
These programs complement AnimalHealth.vc and reflect the hands-on development experience that helped shape the broader AHVC platform.
| Program | Therapeutic Area | Target opportunity | Status |
|---|---|---|---|
| SPV-Bactilys | Respiratory and immune health | Oral immune-support approach for respiratory health in horses and cats. | USDA jurisdiction & reviewer assignment completed. Budgets for equine and feline proof-of-concept clinical studies pending. |
| SPV-BenzoVet | Neurology / seizure rescue | Intranasal product intended to provide rapid, practical seizure control for dogs, including at-home use. | Formulation work completed. Pre-INAD meeting pending. No funding needed at this stage. |
Both programs remain in development. SPV formation and any financing are determined program by program; a pipeline listing does not indicate an open offering.